Embed Size (px)
Citation preview
www.pharma-summit.com
Kindly supported by
Shaping future business
3rd international summit
22 and 23 October 2014, nhow Berlin
Prof. Dr Christoph Meinel Hasso PlattnerInstitute
Alexander Würfel AbbVie Germany
Harry Strasser WearableTechnlogies AG
Dr Jan Schluechter Novartis
Joel Dudley Mount Sinai’s IcahnSchool of Medicine
...and other industry experts
Be inspired by...
2 days full of future insights and inspiration
Powerful speeches and panel discussions
10+ hours of networking
Disruption in Healthcare Vol. I-III
15 + international speakers
www.pharma-summit.com
The recent ‘marriage’ of Big Data and Big Pharma –the groundbreaking deal between google and
Novartis – illustrates once again: Healthcare isfundamentally changing. New players are entering the
market. At the same time established stakeholders are willingto rethink their business in order to keep a slice of the cake.
Current surveys prove: Many industry experts expect that pharma’s biggest competitionwill be from companies other than the current competitors. But which is the best way toshape future business? Compete or collaborate? How to implement current developmentslike data mining and wearable technologies into the model?
Our annual forum will exclusively bring together decision makers, thought leadersand innovation experts willing to reshape the future of healthcare. Our Trend-settingtopics include:
• Joint Value Creation as the only viable model in the future• What patients want in 2035 – and how they are going to get it• Why real innovation beyond the R&D realm must happen • Friend or foe? Compete or collaborate? The new entrants in healthcare• Bigger Data, better healthcare? New roads and opportunities
Are you ready to embrace innovation? Experience the inspiring atmosphere on your ownand become part of our open-minded think tank of industry experts.
Your healthy dose of innovation!
• Business Development• Innovation and Strategy• Strategic Alliances and Collaborations• R + D• Product and Brand Management• Key Account Management
Meet decision makers, thought-leaders, innovation experts andentrepreneurs of the pharmaceutical and healthcare industry.
The summit will exclusively bring together dedicated people engaged in:
We are looking forward to welcoming you in Berlin.
Very good.I. Elfering, GlaxoSmithKline
Stimulating andengaging. You leavewith a lot ofactionable insights.M. Sundararajan, Shire
Chal lenging and thought-provoking.C. DeLoach, Vifor FreseniusMedical Care Renal Pharma Ltd
Inspiring eye-opener.A. Pollner, Bayer HealthCare
A great think tank.U. Diegel, iHealthLabs Europe
Great insightsacross a spectrumof innovationstakeholders. Nowlet’s convert theminto ideas thatdeliver a positiveimpact for patients.C. Skelton, AbbVie
www.pharma-summit.com
DAY ONE WEDNESDAY 22 OCTOBER 2014
8.30 Registration and Networking Breakfast
9.00 Welcome by EUROFORUM and The Chair of Day One
9.15 Opening KeynoteSpeaker to be confirmed
9.40 Joint Value Creation – the only viable model in the future• What does joint value creation mean?• What are the success levers and how do I know I am fit for purpose?• What are the real-life learnings and what is the outlook until 2020?Dr Jan Schluechter, Global Head of KAM and Customer ModelInnovation, Novartis
10.00 Smarter Healthcare – where we might see it happen andwhy it's taking so long• Why Healthcare needs to get smarter• What are the building blocks....and the hurdles on the way to
smarter Healthcare?• There is light at the end of the tunnel – examples of current
approaches to Smart HealthcareChris Isler, former Global Head of Solution & ProductDevelopment, Pfizer Integrated Healthcare
10.20 All hands on deck – navigating the payers’ landscape • What do payers really want? The devil in the details.• We are all payers now. Financing innovation.• Population health vs. unit of One.• If data is the currency of the new ecosystem, trust is the
central bank.Patrick Flochel, Global Pharmaceutical Leader, EY
10.40 Panel DiscussionDr Jan Schlüchter, Patrick Flochel, Chris Isler
11.40 Health Economy becomes Digital Economy: product and strategy update for healthcarestakeholders in a nutshellWith doctors and patients being already digital habitats of ourdigital society, the healthcare industry seems to react rather to act.The gap between the potential of digital products and businessmodels and its todays implementation is symptomatic asappellative. This complementary speaker tandem guides theaudience from implementations for internal "digital compatible"corporate structures and processes up to external product andstrategy approaches.Prof. Dr Mike Friedrichsen, Director, The Humboldt School OfDigital BusinessDr Alexander Schachinger, CEO, EPatient RSD – the company forepatient research, strategy, development
12.00 Open Innovation on prescription – Crowdsourcing inHealthcare • Connecting patients, relatives, medical experts and interested
persons• Active knowledge-transfer• Provision of additional & new information• Best practices in Health CareProf. Dr Johann Füller, Chair for Innovation and Entrepreneurship,University of Innsbruck and CEO, HYVE AG
12.20 The Rise of the Social Health Operating System
Jorge Armanet, CEO and Co-Founder, HealthUnlocked
12.40 Real-world effective: designing human-centered servicesfor what happens in real life
Thomas Sutton, Executive Creative Director, frog
13.00 Networking Lunch
14.00 Disruption Times: The 10 biggest innovations in HealthcareJorge Juan Fernández García, Director of e-Health and Health2.0, Hospital Sant Joan de Déu
“It is time for a new approach and thinking in the industry.Everybody talks about a change of the commercial model inHealthcare. Nevertheless still the old push model prevails, wherestakeholder work in their silos, however with diminishing returns.”
"There is lot's of talking about Health 2.0, Connected Health,Remote Care, Personalised Medicine ... what Healthcare reallyneeds are ways to become smarter. Smart = adjective \�smärt\:very good at learning or thinking about things."
Dr Michael C. Müller, Managing Partner,Cepton Stratgies/CRA
11.00 Disruption in Healthcare – Vol. I: Open Your Mind!
What patients want in 2035 – and how they are going to get it! Interactive Warm-up-Session and Coffee BreakProf. Andreas Mack, Dept. Leadership in Digital Communication, The Berlin University of Arts and Managing Partner, Partake
“Payers have a P&L responsibility for ensuring that sick people getaccess to treatment. We need a balance sheet approach to health”.
"In a digital society all businesses have a digital genome."
"Rethinking Healthcare means to see Big Data, Technology-, Digital-and Open Innovation as a source of success for all stakeholders –from pharmaceutical and medical device companies, doctors, caregivers, hospitals, to patients (and their relatives)."
"People (and yes, consumers) at the centre of the knowledgestorage and the healthcare communications flows is the greatestrevolution in the health industry ever and we are yet awaiting forthe raise of the Social Health Operating System that can connectthe dots and accelerate it all."
“Even when medical science has provided us with the technologyand knowledge needed to prevent or cure illness, there remains ahuge gap in what we actually achieve in healthcare outcomes.”
“The only reason why we are interested in technologies is becausethey can help us solve the healthcare conundrum. Or can you thinkof any better ways of providing better care, at a lower cost, andmore accessible?”
www.pharma-summit.com
15.30 Coffee Break
16.15 Chronically Rethinking – what impulses will thepharmaceutical industry require in order to produce realinnovation?• Why real innovation beyond the R&D realm is a necessity for
biopharmaceutical companies • Why real innovation is not a one-way-street but takes a different
time, space and drive – entrepreneurial thinking for establishedstructures
• Why real innovation needs a “design thinking approach” Alexander Würfel, General Manager, AbbVie Germany
16.35 Breaking up the Value Chain • Why does pharma unlock established structures in R&D and
operations• Innovation driven by cooperations• Partnering in R&D• New kids on the block• How to embed new business partnersDr Michael C. Müller, Managing Partner, Cepton Strategies/CRA
16.55 Packs, Drugs & Rock 'n' Roll! Abba and Antibodies,Aerosmith and Aspirin. An inspiring Medley of Change infive Acts.
Tobias D. Gantner, MD, MBA, LL.M., CEO, HealthCare FuturistsGmbHAleksandar Stojanovic, Founding Partner, Neon Bridges Consortium,HealthCare Futurist
17.15 The 'Google-ization' of healthcareDr Stephan Sigrist, Head of the W.I.R.E. (Web forInterdisciplinary Research & Expertise)
17.30 Panel DiscussionFriend or foe? Compete or collaborate? Who will be theindustry's next amazon?Dr Stephan Sigrist, Alexander WürfelMore panelists to be announced
18.00 The Chair's TakeawaysDr Michael C. Müller
14.30 Disruption in Healthcare – Vol. II: Get Envolved!
Interactive Collaboration SessionHow disruptive business models will empower patients andrevolutionize healthcare industries
“To deliver real patient-centric innovation, it takes more than atraditional innovation approach: facing today’s challenges in theeconomy and society (such as the demographic change) we needto reconsider our ways of thinking and working.”
19.00 Berlin at night
Let your hair down after a busy day. We invite you to enjoy dinnerand drinks in a relaxed atmosphere.
“Big money. Big players. Big aspirations. Both Rockstars andBlockbusters are all about turning IP into value. Yet today, theMajor Record Labels are all gone - blown away by DigitalTransformation. Now, Big Pharma moves along the samedestructive path of downfall - stuck between denial and a deepwish for people-centricity. What has to change in order to keep themusic playing nice and loud?”
16.00 Disruption in Healthcare – Vol. III: Get the results!
DAY ONE CONTINUED
www.pharma-summit.com
DAY TWO THURSDAY 23 OCTOBER 2014
8.00 Networking Breakfast
9.00 Welcome by EUROFORUM and The Chair of Day Two
9.15 Big Data – promise or threat? Prof. Dr Christoph Meinel, Head and Executive Director, Hasso-Plattner-Institute (HPI)
9.35 Wearable Technologies transforming the healthcareindustriesSo far the internet of things hasn’t made much headway intopatient care in the medical setting, but consumers are buyingwellness devices for a variety of reasons. Will the medical worldembrace that data?• Overview and trends of wearable technologies• Innovations in healthcare, fitness and wellness markets• Opportunities and challengesHarry Strasser, Managing Partner, Wearable Technologies AG
9.55 In the hospital of the future data is one of your doctorsJoel Dudley, PhD, Director of Biomedical Informatics, AssistantProfessor of Genetics and Genomic Sciences, Institute forGenomics and Multiscale Biology, Icahn School of Medicine,Mount Sinai Hospital
10.15 Disrupting patient stratification and diagnostics withPattern Discovery & Machine Learning – What Pharma can learn from the CIA• The convergence of IT and biomedicine now enables molecular
maps of health/disease• Pattern discovery & machine learning allow new approaches to
stratify customers/patients• The challenges, however, range from a lack of standards for
data harvesting to the general reluctance to explore enchantedground; i.e. “risk” avoidance
Dr. Thomas Wilckens, CEO/CSO, InnVentis
10.35 Panel DiscussionBigger Data, better Healthcare? New roads and opportunitiesJoel DudleyHarry StrasserDr Thomas Wilckins
11.00 Coffee and Networking Break
11.30 Panel DiscussionPill, patient and outcome Panelists to be announced.
12.00 Panel DiscussionOpportunity for commercial analytics Panelists to be announced.
13.15 The Chair's TakeawaysGerd W. Stuerz
13.30 Networking Lunch
14.30 Close of the summit
“Big Data are the “el Dorado” of the future particularly in the fields ofpharma and healthcare. It provides the possibility to perform clinicalstudies with large number of participants and to computationallyanalyze any kind of huge health data sets from clinics or insurancecompanies. Investigating such large data sets makes it possible toidentify how various things stick together. The highly complex medicaland pharmaceutical industry can medically benefit the most by theextensive correlations of their new on Big Data-based technologies.”
"In future patients will not go anymore to their doctor whenfeeling sick, but expect to be called when showing signs of illness."
“The future is bright, but traditional players will soon face fiercecompetition from the early adopters of Big DATA and the emergingPRECISION MEDICINE paradigm like Google with CALICO, NanthHealth,Human Longevity just to name the financially best backed players.”
12.30 Energizing Health
It’s Pecha Kucha Time!Meet young entrepreneurs ready to revolutionize the healthcaremarket:20 slides, 20 seconds time per slide = 6.40 to surprise andimpress you with their innovative ideas
Gerd W. Stuerz, Managing Partner LifeSciences, Healthcare and Chemicals,Germany, Switzerland and Austria, EY
Located directly on the banks of the river Spree the nhowstands for a new generation of hotels: offbeat, lively, dynamic.Get inspired by the Berlin kind of way.
Your venue
www.pharma-summit.com
GET TO THE HEART OF THE MATTER WITH:
Jorge ArmanentHealthUnlocked
Joel Dudley PhDMount Sinai Hospital
Patrick FlochelEY
Prof. Dr Mike FriedrichsenThe Humboldt School ofDigital Business
Prof. Dr Johann FüllerHYVE AG
Chris Islerformer Pfizer IntegratedHealthcare
Jorge Juan Fernández GarciaHospital San Joan de Déu
Tobias D. GantnerHealthCare Futurists
Prof. Andreas MackPartake
Aleksander StojanovicNeon BridgesConsortium
Dr Stephan SigristThe W.I.R.E.
Dr Alexander SchachingerEPatient RSD
Harry StrasserWearable TechnologiesAG
Thomas Suttonfrog
Gerd W. StuerzEY
Alexander WürfelAbbVie Germany
Dr Michael C. MüllerCepton Strategies/CRA
Dr Jan SchlüchterNovartis
Dr Thomas WilckinsInnVentis
www.pharma-summit.com
CONFERENCE PARTNER
About EY’s Global Life Sciences Center
Life sciences companies are facing challenging but promising times, as businessmodels evolve, stakeholder expectations increase, new markets emerge, demographicsshift, new technologies flourish, populations age and health care expenditures rise.EY‘s Global Life Sciences Center brings together a worldwide team of professionals tohelp you achieve your potential— a team with deep technical experience in providingassurance, tax, transaction and advisory services. The Center works to anticipatemarket trends, identify the implications and develop points of view on relevantindustry issues. It’s how EY makes a difference. For more information, please visitwww.ey.com/lifesciences or email [email protected].
EY Maagplatz 1, 8010 Zürich, Switzerlandwww.ey.com
PARTNER
AbbVie is a global, research-based biopharmaceutical company which combines thefocus and passion of a leading-edge biotech with the expertise and structure of along-established pharmaceutical leader. The company's mission is to use itsexpertise, dedicated people and unique approach to innovation to develop andmarket advanced therapies that address some of the world's most complex andserious diseases.
AbbVie Deutschland GmbH & Co. KG Mainzer Straße 81, 65189 Wiesbadenwww.abbvie.de
COMPANY PRESENCE
The German capital region is one of the leading life sciences and healthcare industrycenters in the world. At the interface of business, science and clinics, theHealthCapital cluster management drives networking and the technology transferand supports companies interested in relocating to the region. Berlin Partner forBusiness and Technology and ZAB Brandenburg Economic Development Board areresponsible for managing the cluster.
Berlin Partner für Wirtschaft und Technologie GmbHHealthCapital Berlin-Brandenburg Fasanenstr. 85, 10623 Berlinwww.healthcapital.de
MEDIA PARTNERS
Make it your eventBecome partner of our summit!
We offer various packages of marketing and sponsoring opportunitiestailored to your personal needs. Let’s discuss your ideas!
+49(0)211/96 86-37 34
Annette Schwartze Sponsoring & Exhibition
@events_health#rethinkhealth
Fol low us on twitter Rethinking Healthcare –Internatiional Summit
Join our LinkedIn Group
Questions?Please contact us: +49(0)211/9696-3599
Programme matters Friederike [email protected]
Organisation and customer enquiries Dana Knabbe [email protected]
Marketing and media partnerships Dörte [email protected]
registrationcodePersonal
EUROFORUM Deutschland SE, Postfach 11 12 34, 40512 Düsseldorf
08:58
www.pharma-summit.com
Rethinking Healthcare
Are you ready to embrace innovation?22 and 23 October 2014, Berlin
Terms and conditions:http://www.euroforum.de/agben
More info and register
Online:www.pharma-summit.com/registration
Email: [email protected]
Phone:+49(0)211/9686-3599
Pricing
Standard rate at the price of € 1,999 p.p. plus VAT
Your Venue:
nhow Hotel Berlin Stralauer Allee 3, 10245 Berlin Germany
Phone:+49(0)30/290299-0
For the latest updates including last year's conferencereport, please visit: www.pharma-summit.com
